Venturelab
close

Predicting the risk of premature birth

Pregnolia AG

Swiss Startup - Pregnolia Profile Main Image
Incorporated
13.01.2016
Headquarters
Schlieren
Support

pregnolia is a women’s health medtech company, developing a diagnostic device to accurately predict the risk of premature birth during routine pregnancy consultation. Early diagnosis enables preventive intervention to prolong gestation and improve neonatal health outcome. pregnolia’s proprietary technology addresses both the health and economic challenges of preterm birth.

News

16.11.2023

Pregnolia sichert sich 2.2 Millionen Franken (startupticker.ch)

31.03.2022

A second cohort joins Tech4Eva accelerator (startupticker.ch)

10.05.2021

Doppelter Schub für ETH-Spinoff Pregnolia (startupticker.ch)

16.02.2018

Pregnolia closes seed round (startupticker.ch)

Show all
Swiss Startup - Pregnolia Product Image Swiss Startup - Pregnolia Team Image

Videos and Presentations

venture leaders in Life Sciences Boston: meet Sabrina from Pregnolia